Condition

Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma clinical trials and research

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Combining pembrolizumab with radiation therapy for bladder cancer treatment

  This study is testing if combining the immunotherapy drug pembrolizumab with radiation therapy can help people with non-muscle invasive bladder cancer do better than standard chemotherapy during treatment.

  Recruiting at 135 sites Phase 2 National Cancer Institute (NCI) · Tucson, Arizona and 146 other locations · NCT06770582

• Bicalutamide for non-muscle invasive bladder cancer

  This trial tests whether the anti-androgen drug bicalutamide changes EGFR protein expression in adult men with non-muscle invasive bladder cancer.

  Recruiting at 3 sites Phase 1 University of Wisconsin, Madison · Tucson, Arizona and 5 other locations · NCT05521698

Related topics

Quick answers

How many Recurrent Non-Muscle Invasive Bladder Urothelial Carcinoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →